Xeris Biopharma Holdings Inc (XERS)
Operating Cash Flow Growth
4440.11%
Quarterly · Period ending:
XERS Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported4440.11%period ending
Latest reported4440.11%period ending
XERS Quarterly Cash from Operations YoY % (-121.80% → 4440.11%)
Year-over-year change
High-resolution chart · PNG
XERS operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 4,440.1099% | |
| 198.395% | |
| 914.8354% | |
| 321.9386% | |
| 101.7588% | |
| 50.5935% | |
| -68.581% | |
| 43.1554% | |
| 24.709% | |
| 22.3298% | |
| 138.9975% | |
| 17.7087% | |
| 33.3107% | |
| 46.0018% | |
| 44.3135% | |
| 21.4807% | |
| -2.9318% | |
| -102.0746% | |
| -166.317% | |
| -33.1233% | |
| 15.7288% | |
| 17.2361% | |
| 63.2456% | |
| 44.4626% | |
| -3.1341% | |
| -36.8299% | |
| -61.2872% | |
| -92.1405% | |
| -61.9814% | |
| -171.0314% | |
| -101.4835% | |
| -185.4043% | |
| -119.9165% | |
| -121.796% |